Low Doses of Interferon Alpha Result in More Effective Clinical Natural Killer Cell Activation.
Journal of Clinical Investigation - United States
doi 10.1172/jci111905
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 1985
Authors
Publisher
American Society for Clinical Investigation